Asthma Trial, Recruiting NCT04706988 Sponsor: Chinese University of Hong Kong Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT04706988
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old who have been diagnosed with asthma according to the 2020 Global Initiative for Asthma (GINA) guidelines.
  • People whose asthma has been confirmed by medical testing showing that their airways respond to a reliever medication (with breathing capacity improving by a specific amount), or that their airways are unusually sensitive when tested under controlled conditions.

Who may not be able to join:

  • People who have other known lung or breathing conditions, such as chronic obstructive pulmonary disease (COPD), bronchiectasis, lung damage from tuberculosis, a history of having part of a lung removed, or lung cancer.
  • People over 40 years old who have a significant smoking history (more than 10 pack-years) or who have had heavy exposure to smoke from burning wood, charcoal, or similar materials.
  • People who are currently taking part in another clinical trial.
  • People who are pregnant.
  • People who are currently smoking, or who have not stopped smoking within the past year.
  • People who have taken antibiotic medicines by mouth, injection, or nasal spray within the past 4 weeks.
  • People who have had signs or symptoms of a respiratory infection (such as a cold, flu, or chest infection) within the past 4 weeks.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fanny Ko, MD, Chinese University of Hong Kong

Phone: +852 35053133

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 June 2021
Est. completion
31 December 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

Microbiome pattern

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov